Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

被引：0
|
作者：
Abdul Miah
Gabriel Tinoco
Songzhu Zhao
Lai Wei
Andrew Johns
Sandip Patel
Mingjia Li
Madison Grogan
Gabrielle Lopez
Marium Husain
Rebecca Hoyd
Khalid Mumtaz
Alexa Meara
Erin M. Bertino
Kari Kendra
Daniel Spakowicz
Gregory A. Otterson
Carolyn J. Presley
Dwight H. Owen
机构：
[1] The Ohio State University Comprehensive Cancer Center,Division of Medical Oncology, Department of Internal Medicine
[2] The Ohio State University Comprehensive Cancer Center,Department of Biomedical Informatics and Center for Biostatistics
[3] The Ohio State University,Division of Gastroenterology Hepatology and Nutrition
[4] The Ohio State University Comprehensive Cancer Center,Division of Rheumatology and Immunology, Department of Internal Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Immunotherapy; Immune checkpoint inhibitor (ICI); Hepatitis; Liver injury; Hepatotoxicity; Immune-related adverse event (irAE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2235 / 2242
页数：7
相关论文
共 50 条
  • [31] Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma
    Hamzah Abu-Sbeih
    Faisal S. Ali
    Wei Qiao
    Yang Lu
    Sapna Patel
    Adi Diab
    Yinghong Wang
    Cancer Immunology, Immunotherapy, 2019, 68 : 553 - 561
  • [32] Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective
    Karamchandani, Dipti M.
    Chetty, Runjan
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (08) : 665 - 671
  • [33] Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid
    Said, Jordan T.
    Talia, Jordan
    Wei, Erin
    Mostaghimi, Arash
    Semenov, Yevgeniy
    Giobbie- Hurder, Anita
    Chen, Steven T.
    LeBoeuf, Nicole R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 670 - 671
  • [34] Outcomes and Management of Immune Checkpoint Inhibitor-Induced Hypothyroidism: A Retrospective Analysis
    Phillips, Allison L.
    Reeves, David J.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (10) : 1100 - 1105
  • [35] Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis
    Vasbinder, Alexi
    Chen, YeeAnn
    Procureur, Adrien
    Gradone, Allison
    Azam, Tariq U.
    Perry, Daniel
    Shadid, Husam
    Anderson, Elizabeth
    Catalan, Tonimarie
    Blakely, Pennelope
    Nelapudi, Namratha
    Fardous, Mohamad
    Bretagne, Marie C.
    Adie, Sarah K.
    Pogue, Kristen T.
    Leja, Monika
    Yentz, Sarah
    Schneider, Bryan
    Fecher, Leslie A.
    Lao, Christopher D.
    Salem, Joe-Elie
    Hayek, Salim S.
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 689 - 700
  • [36] Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus
    Liu, Jia
    Shi, Yuequan
    Liu, Xiaoyan
    Zhang, Dongming
    Zhang, Haoran
    Chen, Minjiang
    Xu, Yan
    Zhao, Jing
    Zhong, Wei
    Wang, Mengzhao
    TRANSLATIONAL ONCOLOGY, 2022, 24
  • [37] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [38] HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
    Correale, Pierpaolo
    Saladino, Rita Emilena
    Giannarelli, Diana
    Sergi, Andrea
    Mazzei, Maria Antonietta
    Bianco, Giovanna
    Giannicola, Rocco
    Iuliano, Eleonora
    Forte, Iris Maria
    Calandruccio, Natale Daniele
    Falzea, Antonia Consuelo
    Strangio, Alessandra
    Nardone, Valerio
    Pastina, Pierpaolo
    Tini, Paolo
    Luce, Amalia
    Caraglia, Michele
    Caracciolo, Daniele
    Mutti, Luciano
    Tassone, Pierfrancesco
    Pirtoli, Luigi
    Giordano, Antonio
    Tagliaferri, Pierosandro
    CELLS, 2020, 9 (09)
  • [39] Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk
    Akturk, Halis Kaan
    Michels, Aaron W.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (03) : 614 - 615
  • [40] Immune checkpoint inhibitor-induced granulomatosis with polyangiitis
    Hung, Whitney
    Cusnir, Ina
    Habib, Syed
    Smylie, Michael
    Solez, Kim
    Yacyshyn, Elaine
    RHEUMATOLOGY, 2021, 60 (06) : E190 - E191
12345